Search Within

Min Yuen Teo

  1. "Surgery"
Formats
  1. Meeting Abstract (28)
  2. Journal Article (21)
  3. Editorial (1)
Groups
  1. Department of Medicine (50)
  2. Genitourinary Oncology Service (50)
  3. Solid Tumor Oncology Division (50)
  4. Surgery (50)
  5. Urology (49)
  6. Department of Pathology and Laboratory Medicine (42)

More Groups

People
  1. Gopakumar Iyer (44)
  2. Jonathan Rosenberg (40)
  3. Dean Bajorin (38)
  4. Hikmat Al-Ahmadie (38)
  5. Bernard Bochner (37)
  6. David Solit (33)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (7)
  4. 2022 (10)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Modern Pathology (4)
  3. Clinical Cancer Research (3)
  4. Laboratory Investigation (3)
  5. Bladder Cancer (2)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (24)
  2. American Association for Cancer Research (5)
  3. Nature Publishing Group (5)
  4. Nature Research (4)
  5. Biomed Central Ltd (2)
  6. Cell Press (2)

More Publishers

Results (50)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final results of a multicenter prospective phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Yip, W.; Coleman, J.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Pietzak, E. J.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Favorable toxicity of chemoradiation for muscle-invasive bladder cancer in elderly, frail patients
    Meeting Abstract

    Moore, A.; Zhang, Z.; Bochner, B. H.; Donahue, T. F.; Rosenberg, J. E.; Iyer, G.; Funt, S. A.; Bajorin, D. F.; Teo, M. Y.; Aggen, D. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Incidence and clinical outcomes of HER2-altered bladder cancer (BC) patients (pts)
    Meeting Abstract

    Lattanzi, M.; Niederhausern, A.; Zheng, J.; Bahadur, N.; Nichols, C.; Barton, L.; Gandhi, F.; Chan, K.; Insinga, A.; Philip, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: A multicenter, single-arm, phase II trial
    Journal Article

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H.; Quinlan, C.; Teo, M. Y.; Lee, C. H.; Aggen, D.; Zimmerman, D.; McHugh, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • CD274 (PD-L1) copy number changes (gain) & response to immune checkpoint blockade therapy in carcinomas of the urinary tract
    Journal Article

    Gupta, S.; Vanderbilt, C. M.; Zhang, Y.; Tickoo, S. K.; Fine, S. W.; Gopalan, A.; Chen, Y. B.; Sirintrapun, S. J.; Teo, M. Y.; Funt, S. A.; more...
    Bladder Cancer (2021)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial
    Meeting Abstract

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H. A.; Quinlan, C.; Teo, M. Y.; Kamradt, J.; Khalil, M. F.; Ostrovnaya, I.; McCoy, A. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience
    Meeting Abstract

    Guercio, B. J.; Gandhi, J.; Teo, M. Y.; Lattanzi, M.; Funt, S. A.; Aggen, D. H.; Chen, Y. B.; Fine, S.; Pietzak, E. J.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Biochemical response (PSA0) and testosterone (T) recovery in Metacure, a multi-arm multi-modality (MM) therapy (tx) for very high risk localized (HRL) and low volume metastatic (LVM) prostatic adenocarcinoma
    Meeting Abstract

    Teo, M. Y.; McBride, S.; Gopalan, A.; Benoliel, H.; Eastham, J. A.; Goh, A.; Szmulewitz, R.; Morgans, A. K.; Bubley, G.; Gupta, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
    Journal Article

    Teo, M. Y.; Al-Ahmadie, H.; Seier, K.; Tully, C.; Regazzi, A. M.; Pietzak, E.; Solit, D. B.; Tickoo, S.; Reuter, V.; Cha, E. K.; more...
    British Journal of Cancer (2021)

    Fulltext@MSK | Save